Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

1606 Corp CBDW

1606 Corp. is a technology company, focused on artificial intelligence (AI) chatbots. The Company specializes in building and merchandizing AI Chatbots for the cannabidiol (CBD) industry and AI Chatbots for public companies. ChatCBDW chatbot offers CBD and wellness merchants the ability to improve sales by providing product recommendations, track user behavior for inventory management, and ChatCBDW can also provide information on products and education around the clock. ChatCBDW is a proprietary bot fully integrated with ChatGPT, a language model developed by OpenAI. This integration equips ChatCBDW with natural language processing (NLP) and machine learning capabilities, allowing lifelike conversations and intelligent product recommendations. IRChat is a chatbot that is able to go on a public company’s website and pull-down vital information for investors and shareholders. Examples of this vital information include SEC filings, company updates and press releases, and others.


GREY:CBDW - Post by User

<< Previous
Bullboard Posts
Next >>
User Avatar Image
(6)
•••
  • StockHighAlertX
Post by StockHighAlerton Nov 26, 2024 11:13am
67 Views
Post# 36331241

Explore the most recent blog from 1606. $CBDW

Explore the most recent blog from 1606. $CBDW

Adnexus Biotechnologies and Sanctum Therapeutics Announce Groundbreaking Merger: A Pivotal Moment in the Fight Against HIV and Infectious Diseases

1606 Corporation (CBDW) recently announced a 5% LOI stake in Adnexus Biotechnologies

In a landmark development that promises to transform the future of medical research and treatment, Adnexus Biotechnologies and Sanctum Therapeutics have announced a strategic merger aimed at revolutionizing the way we combat HIV and other infectious diseases. This fusion of cutting-edge artificial intelligence (AI)-driven drug discovery with breakthrough therapeutic innovations marks a pivotal moment in the ongoing battle against some of the world’s most persistent and deadly diseases.

Together, the combined entity stands poised to accelerate the development of life-saving therapies that have the potential to change the lives of millions of people globally. The merger not only signals a significant advancement in the fight against HIV but also showcases the power of technological innovation in advancing global healthcare.


 

<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities